New sugar a treat for diabetes treatment

Dr Simeonovic and Professor Parish. Photo by Karen Edwards.

(Medical Xpress) -- Researchers from The Australian National University have discovered a new treatment for Type-1 diabetes – an autoimmune disease which currently affects some 130,000 Australians.

Dr Charmaine Simeonovic and Professor Christopher Parish from The John Curtin School of Medical Research have identified a previously unknown process which causes destruction of the insulin-producing beta cells in the pancreas. The researchers found that the insulin-producing cells need a complex sugar, heparan sulphate, for their survival.

Beta cells are one of five cell types found in the pancreas and produce insulin – a hormone which helps move sugars from the food we eat into cells in our body for energy. In the human body’s immune system destroys these cells by mechanisms that are not well understood.

Dr Simeonovic said that their research has shown that beta cells found in the pancreas need heparan sulphate for their survival and without it they die.

“We’ve discovered that replacement of heparan sulphate in the beta cells rescues the cells from dying and prevents them from damage caused by oxidation. This new work has identified heparan sulphate depletion in beta cells as a major cause of beta cell death.

“We attribute this cell death to loss of the beta cells’ normal defence against damage by oxidation caused by free radicals, or highly chemically reactive atoms, molecules or ions.”

The study also revealed that the autoimmune cells in the immune system damage beta cells by producing the enzyme heparanase, which degrades heparan sulphate in beta cells.

“Treatment with a heparanase inhibitor, PI-88, was shown to preserve heparan sulphate in the of the pancreas and protect against Type-1 diabetes,” said Dr Simeonovic.

“This has revealed a new understanding of the development of Type-1 and has identified a new therapeutic strategy for preventing progression of the autoimmune disease and associated complications.”

Professor Parish added that the researchers are already taking the medical breakthrough from the bench to the bedside.

“We’re developing new drugs to take advantage of this discovery. A start-up biotechnology company, Beta Therapeutics, has been set up to translate our findings to the clinic,” said Professor Parish.

The researchers’ breakthrough has been published today in The Journal of Clinical Investigation.

Provided by Australian National University

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Scientists find a new way insulin-producing cells die

Feb 25, 2011

The death of insulin-producing beta cells in the pancreas is a core defect in diabetes. Scientists in Italy and Texas now have discovered a new way that these cells die — by toxic imbalance of a molecule secreted by ...

Compounds that trigger beta cell replication identified

Feb 25, 2009

Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput ...

Recommended for you

Growing a blood vessel in a week

Oct 24, 2014

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

Oct 24, 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

PPihkala
not rated yet Dec 20, 2011
I think the next obvious thing to study would be why some people have too much heparanase in their pancreas and how that can be modified without drugs.